Oculis Holding AG (FRA:CR5) Total Stockholders Equity : €81.83 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Total Stockholders Equity?

Oculis Holding AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €81.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Oculis Holding AG's Book Value per Share for the quarter that ended in Mar. 2024 was €2.23. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Oculis Holding AG's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

Oculis Holding AG Total Stockholders Equity Historical Data

The historical data trend for Oculis Holding AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Total Stockholders Equity Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

-40.39

-58.57

-99.30

99.39

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial							-	120.14	109.99	99.39	81.83

Oculis Holding AG (FRA:CR5) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Oculis Holding AG's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(81.826	-	0)	/	36.7403
	=	2.23

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Oculis Holding AG's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.188	+	0.426)	/	81.826
	=	0.01

Oculis Holding AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (FRA:CR5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

OCS:USA CR5:Germany

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines